Cedar Mountain Advisors
WST icon

Cedar Mountain Advisors’s West Pharmaceutical WST Stock Holding History

Cedar Mountain Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.53K Hold
23
– – ﹤0.01% 514
2026
Q2 		$8.26K Hold
23
– – ﹤0.01% 543
2026
Q1 		$5.76K Buy
23
+13
+130% +$3.24K ﹤0.01% 608
2025
Q4 		$2.75K Hold
10
– – ﹤0.01% 371
2025
Q3 		$2.62K Buy
+10
New +$2.43K ﹤0.01% 393

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Cedar Mountain Advisors's WST Position: Q3 2026 in Review

Cedar Mountain Advisors held its West Pharmaceutical (WST) position steady in Q3 2026 at 23 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Cedar Mountain Advisors first reported a position in WST in Q3 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Cedar Mountain Advisors held 23 shares of West Pharmaceutical worth $8.53K as of Q3 2026.
  • Cedar Mountain Advisors left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #514 holding.
  • Cedar Mountain Advisors first reported a position in West Pharmaceutical in Q3 2025 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.